진단용 영상 장비 시장 : 제품 유형별, 휴대성별, 환자 연령층별, 용도별, 최종 사용자별 시장 예측(2026-2032년)

The Diagnostic Imaging Equipment Market is projected to grow by USD 47.09 billion at a CAGR of 6.67% by 2032.

Diagnostic imaging equipment is the clinical backbone of modern healthcare, spanning MRI systems, CT scanners, X-ray systems, ultrasound, mammography, fluoroscopy, and nuclear medicine platforms. Demand is supported by verified structural drivers: the World Health Organization identifies noncommunicable diseases, including cancer and cardiovascular disease, as the dominant global health burden, while UN demographic data show rapid growth in older populations that require more frequent diagnostic evaluation.

Hospitals, imaging centers, and ambulatory care networks are investing in higher-throughput, lower-dose, and digitally connected imaging assets to improve early diagnosis, emergency response, and chronic disease management. Competitive advantage is increasingly tied to image quality, lifecycle service, AI-enabled workflow, interoperability with PACS/RIS/EHR systems, cybersecurity readiness, and the ability to support value-based care models.

Transformative Shifts in the Imaging Landscape

The diagnostic imaging equipment landscape is shifting from standalone hardware purchasing toward integrated imaging ecosystems. Providers are prioritizing digital radiography, portable ultrasound, hybrid operating-room imaging, cloud-enabled image management, and service-based procurement models that reduce downtime and improve asset utilization. Low-dose CT, photon-counting CT, accelerated MRI reconstruction, and advanced ultrasound visualization are reshaping clinical expectations for precision and speed.

At the same time, radiology workforce constraints are accelerating adoption of automation, remote reading, and workflow orchestration. Regulatory scrutiny, data protection requirements, and reimbursement pressures are making evidence generation essential. Vendors that combine reliable hardware, secure software, scalable service contracts, and measurable clinical productivity gains are better positioned than suppliers focused only on equipment specifications.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative impact across the imaging value chain, from scan acquisition and image reconstruction to triage, detection support, reporting assistance, and quality assurance. The U.S. FDA's public list of AI/ML-enabled medical devices shows radiology as the largest application area, confirming that diagnostic imaging is a primary commercialization pathway for regulated healthcare AI.

The strongest near-term value is operational: shorter scan times, reduced repeat imaging, prioritization of urgent findings, improved radiologist productivity, and more consistent protocol adherence. However, AI adoption requires validation across patient populations, continuous performance monitoring, cybersecurity controls, explainability, and alignment with regulations such as FDA requirements, EU MDR expectations, and local data governance rules.

Key Regional Insights Across Global Imaging Markets

North America remains a high-value diagnostic imaging equipment region due to advanced hospital infrastructure, broad use of cross-sectional imaging, established reimbursement pathways, and rapid adoption of AI-enabled radiology tools, with the United States and Canada supporting demand for MRI systems, CT scanners, ultrasound equipment, digital X-ray systems, mammography, and nuclear medicine platforms. Europe is shaped by universal healthcare systems, EU MDR compliance, radiation dose-reduction priorities, interoperability requirements, and continued investment in digital health infrastructure. Asia-Pacific is the fastest-changing regional landscape, driven by hospital expansion, aging populations in Japan and South Korea, China's domestic manufacturing scale, and India's growing diagnostic access initiatives.

Latin America is improving access through private imaging networks and public hospital modernization, with Brazil and Mexico central to regional equipment procurement and service demand. The Middle East is investing in premium hospital infrastructure, oncology centers, emergency care capacity, and digital health programs, particularly across high-income Gulf health systems. Africa continues to face equipment access, maintenance, skilled workforce, and uptime constraints, making mobile imaging, refurbished systems, tele-radiology, biomedical engineering support, and public-private partnerships central to diagnostic imaging market development.

Key Group Insights for Imaging Equipment Demand

ASEAN diagnostic imaging equipment demand is supported by expanding private hospitals, medical tourism, and government investment in diagnostic capacity, though procurement remains highly price-sensitive outside major urban centers. GCC countries are adopting advanced MRI, CT, nuclear medicine, digital X-ray, and AI-supported imaging as part of healthcare diversification strategies and specialty care development. The European Union emphasizes regulatory compliance, radiation safety, interoperability, data protection, health technology assessment, and sustainable procurement across public health systems.

BRICS markets combine large patient populations with rising local manufacturing capability, expanding tertiary care networks, and uneven diagnostic access between metropolitan and rural care settings. G7 countries represent mature, innovation-led imaging markets where replacement cycles, precision oncology, cardiac imaging, neuroimaging, women's health screening, and AI workflow efficiency shape procurement decisions. NATO-aligned healthcare systems also prioritize resilient medical infrastructure, cybersecurity, emergency preparedness, and deployable healthcare capacity, increasing the strategic value of connected imaging platforms and secure image management.

Key Country Insights Shaping Competitive Strategy

The United States leads in advanced imaging utilization, AI-enabled radiology adoption, outpatient imaging networks, and innovation partnerships, supported by strong clinical demand for CT, MRI, ultrasound, mammography, and interventional imaging. Canada emphasizes public system modernization, access management, and imaging wait-time reduction, while Mexico benefits from private diagnostic growth, cross-border healthcare activity, and nearshoring-related healthcare investment. Brazil is Latin America's largest imaging opportunity, supported by private hospital groups, urban diagnostic centers, oncology demand, and efforts to expand public-sector diagnostic access.

In Europe, the United Kingdom is focused on imaging backlog reduction, community diagnostic capacity, and workforce productivity; Germany benefits from high-quality hospital technology, specialist care infrastructure, and domestic medtech strength; France emphasizes public hospital modernization and cancer care pathways; Italy and Spain continue regional healthcare upgrades; and Russia is shaped by import substitution pressures, localization policies, and constrained access to certain advanced technologies. China combines large-scale demand with domestic equipment growth and hospital modernization, India prioritizes affordability, access, and scalable diagnostic networks, Japan and South Korea advance high-end imaging innovation for aging populations and specialty care, and Australia invests in distributed diagnostic access for urban, rural, and remote populations.

Actionable Recommendations for Industry Leaders

Industry leaders should align product strategy with clinical productivity, not only image resolution. Winning diagnostic imaging equipment portfolios will demonstrate lower total cost of ownership, higher uptime, faster exams, dose optimization, seamless PACS/EHR integration, cybersecurity resilience, and measurable support for oncology, cardiology, neurology, emergency medicine, orthopedics, and women's health pathways.

Firms should invest in AI governance, post-market monitoring, cybersecurity, service quality, clinical evidence generation, and regulatory readiness to support buyer confidence. Regional strategy should balance premium systems in mature markets with scalable, serviceable, training-supported, and financing-friendly equipment for emerging markets. Partnerships with hospitals, cloud infrastructure providers, academic centers, public health systems, and tele-radiology networks can accelerate adoption while improving diagnostic access and workflow resilience.

Research Methodology

This executive summary is based on a structured review of validated public and industry sources, including regulatory databases, public health datasets, hospital infrastructure trends, peer-reviewed radiology literature, medical device policy updates, and procurement indicators. Sources considered include the World Health Organization, U.S. FDA, European Commission, OECD, UN population datasets, national health authorities, radiology practice guidelines, and medical device regulatory publications.

The methodology applies cross-verification and triangulation to separate durable market signals from short-term noise. The review evaluates clinical demand drivers, technology adoption, regional healthcare capacity, reimbursement conditions, regulatory frameworks, competitive positioning, end-user purchasing behavior, cybersecurity requirements, and service delivery models to produce practical insights for diagnostic imaging equipment stakeholders.

Conclusion

The diagnostic imaging equipment market is entering a period defined by precision, connectivity, automation, and access expansion. Aging populations, chronic disease prevalence, cancer screening needs, emergency care requirements, and specialty care pathways continue to support long-term demand for MRI systems, CT scanners, X-ray equipment, ultrasound systems, mammography platforms, fluoroscopy, and nuclear medicine solutions.

Future leadership will depend on more than hardware innovation. Organizations that integrate AI responsibly, strengthen service models, prove clinical and economic value, protect imaging data, and adapt to regional access gaps will be best positioned. The market direction favors stakeholders that convert imaging technology into faster diagnosis, better workflow, lower operational risk, improved care coordination, and stronger patient outcomes.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Diagnostic Imaging Equipment Market, by Product Type

• 7.1. Computed Tomography (CT) Scanners
  • 7.1.1. High-Slice CT Scanners
  • 7.1.2. Low-Slice CT Scanners
  • 7.1.3. Mid-Slice CT Scanners
• 7.2. Magnetic Resonance Imaging (MRI) Equipment
  • 7.2.1. Closed MRI Systems
  • 7.2.2. Open MRI Systems
• 7.3. Nuclear Imaging Equipment
  • 7.3.1. PET Systems
  • 7.3.2. SPECT Systems
• 7.4. Ultrasound Systems
  • 7.4.1. 2D Ultrasound Systems
  • 7.4.2. 3D & 4D Ultrasound Systems
  • 7.4.3. Doppler Ultrasound Systems
• 7.5. X-Ray Systems
  • 7.5.1. Analog X-Ray Systems
  • 7.5.2. Digital X-Ray Systems

8. Diagnostic Imaging Equipment Market, by Portability

• 8.1. Fixed Imaging Equipment
• 8.2. Portable Imaging Equipment
  • 8.2.1. Handheld Portable Devices
  • 8.2.2. Transportable Equipment

9. Diagnostic Imaging Equipment Market, by Patient Age Group

• 9.1. Adult
• 9.2. Pediatric

10. Diagnostic Imaging Equipment Market, by Application

• 10.1. Cardiology
  • 10.1.1. Coronary Imaging
  • 10.1.2. Vascular Imaging
• 10.2. Neurology
  • 10.2.1. Brain Scans
  • 10.2.2. Spinal Cord Imaging
• 10.3. Obstetrics & Gynecology
  • 10.3.1. Fetal Monitoring
  • 10.3.2. Pelvic Imaging
• 10.4. Oncology
  • 10.4.1. Early Detection
  • 10.4.2. Staging & Monitoring
• 10.5. Orthopedics
  • 10.5.1. Fracture Detection
  • 10.5.2. Joint Examination

11. Diagnostic Imaging Equipment Market, by End-User

• 11.1. Ambulatory Care Centers
• 11.2. Diagnostic Imaging Centers
• 11.3. Hospitals & Clinics

12. Diagnostic Imaging Equipment Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Diagnostic Imaging Equipment Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Diagnostic Imaging Equipment Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Agfa-Gevaert Group
• 16.2. Analogic Corporation
• 16.3. Avonix Imaging, LLC by Nikon Corporation
• 16.4. Barco NV
• 16.5. Bracco S.p.A.
• 16.6. Canon Medical Systems Corporation
• 16.7. Carestream Health, Inc.
• 16.8. Esaote S.p.A
• 16.9. FUJIFILM Holdings Corporation
• 16.10. GE HealthCare Technologies Inc.
• 16.11. Hologic, Inc.
• 16.12. Konica Minolta, Inc.
• 16.13. Koninklijke Philips N.V.
• 16.14. Medtronic PLC
• 16.15. MinFound Medical Systems Co., Ltd.
• 16.16. Neusoft Corporation
• 16.17. Olympus Corporation
• 16.18. Planmed Oy
• 16.19. Samsung Electronics Co., Ltd
• 16.20. Shanghai United Imaging Healthcare Co., Ltd.
• 16.21. Shenzhen Mindray Bio-Medical Electronics Co Ltd
• 16.22. Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
• 16.23. Shimadzu Corporation
• 16.24. Siemens Healthineers
• 16.25. Stryker Corporation
• 16.26. Ziehm Imaging GmbH